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Objectives.This studysoughtto examinewhetherlipopro-

















creasedfromcase patientswith a first myocardialinfarction




0.01,test for trend).Womenhad significantlyhigherlipopro-
tein(a)concentrationsthanmen(median71mg/literhigher,95%






High lipoprotein(a)concentrationsmay be a





Lipoprotein(a)is a cholesterol-richlipoproteinthat is struc-
turallyvery similarto low densitylipoproteinbut with an
additionalmoleculeof apolipoprotein(a)(l). The apolipopro-









be associatedwithan increasedriskof coronaryheart disease
(5-8). However,otherstudieshavenot foundthisassociation
(9-12),and there remainsdoubtas to whetherlipoprotein(a)
is a riskfactorfor coronaryheart disease.Furthermore,there
is very little informationon the risk of acute myocardial
infarctionfrom lipoprotein(a)in womenand none in those
withpreexistingcoronaryheart disease.
Thepresentreporttestedthreehypotheses:1)that lipopro-
tein(a)is higherin peopleadmittedto the hospitalfor a first
acutemyocardialinfarctionthanincommunitycontrolsubjects
without a history of acute myocardialinfarction;2) that
lipoprotein(a)ishigherin peoplewitha pastacutemyocardial
infarctionadmitted to the hospital for a recurrent acute
myocardialinfarctionthan in communitycontrolsubjectswith
a historyof acute myocardialinfarction;3) amongpatients
withan acutemyocardialinfarctionadmittedto the hospital,






acute myocardialinfarctionthan in thosewith a first acute
myocardialinfarction.
Methods
Studysubjects.This studywas a population-basedcase-
controlstudyof men andwomen35to 69yearsold and used
data fromparticipantsin a communityriskfactorprevalence
surveyand cases registeredas part of the World Health
OrganizationMonitoringTrendsandDeterminantsofCardio-
vascularDisease(MONICA)Projectin Newcastle,Australia.
For this study,all casesmeetingthe diagnosticcriteriafor
coronarydeath and definiteor possiblenonfatalacutemyo-
cardialinfarctionin the HunterRegionbetweenAugust1993
andMarch1994wereregistered(13).Theseincludedpatients
with first and recurrentmyocardialinfarctions.The control
subjectswere randomlydrawnfromthe electoralroll for the
studyarea (responserate 6670)andwereexaminedfromJune
1994to November1994(registrationon the electoralroll is
compulsoryfor most people in Australia).In both groups
blood was measuredfor lipoprotein(a)and total and high
densitylipoprotein(HDL)cholesterolconcentrations.
The studywas approvedby the Hunter Area Research
Ethics Committeeand the Universi~of NewcastleEthics
Committee.Bothcasepatientsandcontrolsubjectswereasked
the samequestionsabouthistoryof diabetesor hypertension,
currentuse of antihypertensivemedications,smokinghistory
and previousmyocardialinfarction.In this report,hyperten-
sionwas definedas the subjectever havingbeen told by a
doctorthat he or shehad highbloodpressure,or the current
use of medicationsto treat bloodpressure.
Lipid analysis.Bloodfor lipid analysiswas taken from
caseson admissionto the hospital,a mediantime of 2.5 h
(interquartilerange 1 to 5.5 h) fromthe onsetof symptoms.
Thistimeperioddoesnot significantlyaffectthe levelsof total
cholesterol,HDL cholesterolor lipoprotein(a)from those
beforemyocardialinfarction(14).Serumtotalcholesteroland
HDL cholesterolconcentrations(after precipitationby poly-
ethyleneglycol)were measuredusingstandardenzymekits
(15). The laboratoryparticipatesin the AustralianLipid
Standardisationprogram,andthestandardsusedare traceable
to the Centersfor DiseaseControl,Atlanta, Georgia.The
averagebetween-runcoefficientsofvariationduringthe study
periodfromexternalqualitycontrolprogramswere2.2%for
totalcholesteroland 4.1%for HDL cholesterol.




withinthe laboratoryduringthe studyperiod, ranged from
6.4% [mean lipoprotein(a)422 mg/liter]to 12.5% [mean
lipoprotein(a)197mgiliter].
Statistical analysis. Thirty-four samples with lipopro-
tein(a)concentrationsexceedingthe upperlimitsof the assay
werecodedastheupperlimitvalue;to analyzesuchdata,rank
methodswere used.The rank-sumand Kruskal-Wallistests














previousacute myocardialinfarctionand after adjustingfor
other potential explanatoryvariables.Multinominal(polyt-
omous)logisticregressionwasusedto estimatetheoddsratios
of acutemyocardialinfarctionfor quintilesof lipoprotein(a)
concentrationadjustedfor other coronaryheart diseaserisk
factors (age, gender,diabetes,hypertension,smoking,total
and HDL cholesterol).Adjustedodds ratiosfor quintilesof
lipoprotein(a)concentrationwere also estimatedwithinthe
subgroupsof first acute myocardialinfarctionin men and
women. Case and control patients with a previousacute
myocardialinfarctionwere also matchedfor age (t3 years)
and gender to estimateadjustedodds ratios (includingthe




Study subjects.There were 370 case patients and 523
controlsubjects.Table 1 describesthe four groupsof case
patientsand controlsubjectswithouta previousmyocardial
infarctionand the case and controlpatientswith a previous
acute myocardialinfarction.There were more differences
betweencasepatientsand controlsubjectswithouta previous
acutemyocardialinfarctionthan the caseand controlpatients
with a previousacute myocardialinfarction.The median
concentrationsoflipoprotein(a)werenotsignificantlydifferent
betweencasepatientsand controlsubjectsin eithergroup.In
those withouta previousacute myocardialinfarction,case
patientsweresignificantlyolder,weremorelikelyto be men,
had lowerHDL cholesterolconcentrationsand were more
likelyto reportdiabetesand hypertension.
Amongallthe casepatients,the timebetweenthe onsetof









AMI= a&rtemyocardialinfarction. “ -
lipoprotein(a)concentration(r = 0.006,p = 0.9).Themedian
lipoprotein(a)concentrationwassignificantlyhigherin those
with than without a previousacute myocardialinfarction
(median[interquartilerange 25% to 75%]:with a previous




Table 2 showsthe median lipoprotein(a)concentrationfor
differentvariables.Therewereno statisticallysignificantasso-
ciationsbetsveenlipoprotein(a)and age,HDL cholesterolor
bodymassindexin anyof the fourgroups(r <0.15, p > 0.2).
Amongthosewithouta previousacutemyocardialinfarction,
there was a statisticallysignificantbut smallcorrelationbe-
tween total cholesteroland lipoprotein(a)concentrationsin
controlsubjects(r = 0.11,p = 0.02)but not in casepatients







After adjustingfor othervariables,the medianlipoprotein(a)
concentrationin case patientswith a first acute myocardial
infarctionwas slightlyhigherbut not significantlydifferent
fromthat in controlsubjectswithouta previousacutemyocar-
dialinfarction(difference15mg/liter,95%confidenceinterval
ICI] -36 to 66).Lipoprotein(a)concentrationswere signifi-
cantlyhigherin controlsubjectswith than those withouta
previousacutemyocardialinfarction(difference159mgliter,
95%CI interval40 to 278).The medianlipoprotein(a)con-
centrationin case patientswith recurrent acute myocardial
infarctionwashigherbutnotsignificantlydifferentfromthat in
controlsubjectswithouta previousacutemyocardialinfarction
(difference60 mgiliter,95%CI -16 to 136).Subjectswitha
previousmyocardialinfarctionand at a more advancedstage
of coronaryarterydiseasehad a highermedianlipoprotein(a)
concentrationthan thosewitha firstacutemyocardialinfarc-
Figure1. Medianlipoprotein(a)[Lp(a)]concentrations(circles)and




























tion or controlsubjectswithouta previousacutemyocardial
infarction(Fig.1) (testfor trend,p < 0.01).
The onlyother significantassociationwith lipoprotein(a)
concentrationafter adjustingfor othervariableswasa higher
lipoprotein(a)concentrationin womenthan men (difference
71mg/liter,95%CI 23to 118)(Fig.1).
Quintilesoflipoprotein(a)concentrationand risk ofacute
myocardialinfarction.Table 3 showsthe unadjustedand
adjustedodds ratios for acute myocardialinfarctionfrom
quintilesof lipoprotein(a)concentration.After adjustingfor
other risk factors,the highestquintileof lipoprotein(a)con-
centrationwassignificantlyassociatedwithmyocardialinfarc-
tiononlyforprimaryacutemyocardialinfarction.Thispattern
wassimilarin men andwomenseparately.The adjustedodds
ratiosfor the highestquintileof lipoprotein(a)concentration
were2.51(9570CI 1.02to 6.20)forwomenand 1.44(9570CI
0.73 to 2.85)for men. There was no statisticallysignificant
interactionbetweenhighlipoprotein(a)and hightotalcholes-
terolconcentrations.
A high lipoprotein(a)concentrationwas not statistically
significantlyassociatedwith the risk of recurrentacutemyo-
cardialinfarctionin thosewith a previousacute myocardial
infarctionby eithermodel(Table3). The highestquintileof
lipoprotein(a)concentrationwasnot a statisticallysignificant
risk factor for recurrentacute myocardialinfarctionin men
(oddsratio [OR]0.87,95%CI 0.26to 2.90)or recurrentacute
myocardialinfarctionin women(OR 0.46,9570CI 0.03 to
6.46).
Quintilesof lipoprotein(a)concentrationwerenot statisti-
callysignificantlyassociatedwith any evidenceof coronary
arterydisease(casepatientswitha firstor recurrentmyocar-
dialinfarctionandcontrolpatientswitha previousmyocardial
infarction)comparedwith those in healthycontrolsubjects
(secondquintile:0.87[95%CI 0.51to 1.48];third quintile3:
0.93[95%CI 0.56to 1.56];fourthquintile:0.83[95%CI 0.49
to 1.42];fifthquintile:1.64[95%CI 0.97to 2.79]).The odds
ratiosfor quintilesof lipoprotein(a)concentrationfor recur-
rent versusprimaryacute myocardialinfarctionwere all >1
(secondquintile:2.24[95%CIO.89to 5.65];thirdquintile:3.39





acutemyocardialinfarctionand controlsubjects.It is also,to
our knowledge,the firstcase-controlstudyto includesubjects
withrecurrentmyocardialinfarctionandoneof thefewstudies
of lipoprotein(a)concentrationsin a largenumberofwomen.






ated with a higher lipoprotein(a)concentration,and after
adjustingforothercoronaryheartdiseaseriskfactors,women
had significantlyhigherlevelsthan men. Within-population
studieshaveshown(6,9,16,17)that manylife-stylefactorsare
not associatedwith lipoprotein(a)concentrations.Thus, the
findingsof no strongassociationsbetweenlipoprotein(a)con-
centrationand other lipidlevels,hypertension,smoking,dia-




case patients and control subjects,the highestquintileof
lipoprotein(a)was associatedwith a statisticallysignificant
increasedrisk of a firstbut not recurrentacute myocardial
infarction(Table3). The riskof a firstmyocardialinfarction
from a high lipoprotein(a)concentrationis consistentwith
either a modestgradedeffectthat can onlybe identifiedby
comparingthehighestandlowestquintilesoflipoprotein(a)or
perhaps a thresholdeffect.The results for recurrent acute
myocardialinfarctiondo not support any associationwith
lipoprotein(a)concentrations.A limitationof this studywas
that casepatientswho diedbeforetheyreachedthe hospital
were not included.If their lipoprotein(a)concentrationsdif-
feredfromthosesurvivingto hospitaladmittance,our results
mayhavebeen biased.However,it is unlikelythat anybiases
woulddifferbetweenthosewitha firstversusa recurrentevent,
and our results for a first acute myocardialinfarctionare
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and frozenseveralyearsbefore the case patientsdeveloped
coronaryheartdisease.In the LipidResearchClinicsstudyof
hyperlipidemicmen (5), the highesttwo quintilesof lipopro-
tein(a)were significantlyassociatedwithdeath frommyocar-
dial infarction(OR 1.81[95%CI 1.02to 3.19])or coronary
heart disease(OR 2.08 [95%CI 1.19to 3.63]).In a much
smallerstudyfromSweden(6),10(38%)of the 26menwitha
myocardialinfarctionhada lipoprotein(a)concentrationinthe
upper quintile for case patients and control subjects.In
contrast,lipoprotein(a)concentrationswere higherbut not
significantlyassociatedwithcoronaryheart diseasein hyper-
lipidemicmen in the HelsinkiHeart Study (10) (OR for
highestto lowesttertileof lipoprotein(a)1.32[95%CI 0.77to
2.00]).The PhysiciansHealthStudy(11)of middle-agedmen
did not showa significantrisk fromhighlipoprotein(a)con-
centrations(OR 0.83,95$Z0CI 0.36to 1.89),and therewasno
associationwith lipoprotein(a)concentrationand coronary
heart diseasein an earlierstudyof Finnishmen and women
(12).
To our knowledge,only one other retrospectivecase-
control study has examinedthe risk of a first myocardial
infarctionfromhighlipoprotein(a)concentrationsin women
(7).In that studyof a smallergroupofwomen,the oddsratio
forthehighesto lowestertileoflipoprotein(a)was0.79(95%
CI 0.33to 1.89).In contrast,our studyfounda higherodds
ratiofor the highestquintileof lipoprotein(a)inwomenanda
similarpatternofincreasedriskofa firstmyocardialinfarction





giographicstudies,one did not find an associationbetween
lipoprotein(a)concentrationand the progressionof coronary
atheroma1yearlater (21),and the otherdid findan associa-
tionwithhigherlipoprotein(a)concentrationsin patientswho











thrombosis,it wouldbe morebiologicallyplausibleto expect
that the relativeriskshouldbe similarin thoseexperiencinga
recurrentor firstevent.
Another possibleexplanationfor the differencebetween
primaryandrecurrenteventsis that lipoprotein(a)concentra-
tionsmayincreasein somesubjectsin responseto progressive
arterialor tissuedamageor functionalimpairmentof arteries
ratherthancausethesederangementsthatpredisposeto acute
myocardialinfarction.Elevatedlipoprotein(a)concentrations
may be a marker of a late stage in the natural histo~ of
atherosclerosisthatprecedesthe firstmyocardialinfarctionor




myocardialinfarctionto thosewith a first acute myocardial
infarctionto thosewitha previousacutemyocardialinfarction,
as in Figure 1. This hypothesisis also supportedby the
comparisonof case patientswith recurrent versusprimary
acutemyocardialinfarction.Casepatientswithrecurrentacute
myocardialinfarctionwere about twice as likelyto have a
lipoprotein(a)concentrationin any quintileother than the
lowestonecomparedwiththosewitha primaryacutemyocar-
dialinfarction.Thisfindingsuggestsa shiftin the distribution
of lipoprotein(a)such as would occur if more advanced
atherosclerosisled to a general increase in lipoprotein(a)
concentrations.
The marker of injmy hypothesisis also consistentwith
lipoprotein(a)and apolipoprotein(a)findingsin differenteth-
nic groups.The differencesin lipoprotein(a)distributionre-
flectin part the differentfrequenciesof geneticphenotypesof
the apolipoprotein(a)particle,which is a componentof li-
poprotein(a)(23-25).However,only -20% to 50% of the
variationin lipoprotein(a)in differentpopulationsisexplained
byvariationintheapolipoprotein(a)phenotype(24,25).Under





lipoprotein(a)frombloodor leadto a changein theexpression




poprotein(a)concentrationsand primarybut not necessarily
recurrent acute myocardialinfarction.High lipoprotein(a)
concentrationscouldalsobe a causeofprimaryacutemyocar-
dial infarctionbut not increasethe risk of recurrent acute
myocardialinfarctionif the extent of vasculardiseasewas
similarin thosewith a first and thosewith a previousacute
myocardialinfarction.However,in thiscaseonewouldexpect
similar lipoprotein(a)concentrationsin these two groups.
Instead,the lipoprotein(a)concentrationof thosewitha first
acute myocardialinfarctionlies betweenthose withoutand
thosewitha previousacutemyocardialinfarction(Fig.1).
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Conclusions.A highlipoprotein(a)concentrationappears
to be a riskfactorfora firstbutnotrecurrentacutemyocardial
infarction.Highlipoprotein(a)concentrationsmaynot cause
acutemyocardialinfarction.Equallyplausiblehypothesesin-
clude the elevationof lipoprotein(a)concentrationsin re-




In lightof thesesubstantialuncertaintiesaboutthe roleof
lipoprotein(a),unlessit can be shownthat loweringlipopro-
tein(a)concentrationsreducescoronaryheart diseaseor that
the treatment of conventionalcoronaryheart diseaserisk
factorsbenefitsthosewithhighlipoprotein(a)concentrations
morethan thosewithlowerconcentrations,routinemeasure-
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